Member Info for moonparty

Sorry RR, but there is nothing

Thanks WTP. like this:

"Initial projections hoped for a 70% survival rate; clinicians are optimistic about potentially achieving an 85% rate."

My opinion - despite all the gloomies, all the guidance, tonal and body language is that everything is on track. And why wouldn't it be, there is fantastic science behind it,

The doomsters getting desperate, pulling out all the stops - motley fool is too closely connected with the AIM self-appointed cowboys and other self-pocket-lining boiler room scammers for my liking.

It's not "they are evil", it's about understanding motive.

Your motive is opaque, at best. You are not trustworthy. This is obvious to all.

Oh dear, the lunatic has ventured out of his echo chamber.

It"s important to understand that anything over 70% is way ahead of standard of care and should attract industry attention, hopefully mainstream media attention as well.

Not sure how much significance we can assign to "the majority" - I think it's just a legally safe phrase that is easy and gets the point across. If they know the actual number, beyond the 11 out of 13 patients, and it hasn't been RNS'ed, they obviously can't say anything that indicates the actual number.

The recent RNS of annual results has this in it

"As previously reported, the SCIB1 cohort of the SCOPE trial reported exceptional results in the first stage of the study with 11 out of 13 patients showing at least a partial response which is an objective response rate (ORR) of 85%, exceeding the 70% ORR that the trial was configured to show.”

A lot easier, and unlikely to get you in trouble is to say “the majority”.

Though... perhaps we should be setting out our targets in USD?

Lets see what transpires....

I don't especially have a fixed target - will depend on data, deals etc.. but if it comes to fruition as I hope, I would let some go at £2 or thereabouts and hold the rest for higher amounts, possibly for the end game - be that takeover or Scancell becoming a blue chip dividend payer!

Scinv, thought you were retreating back to your cave?

Clearly patient recruitment is not linear - it starts slow for safety, then builds, and gains momentum, especially if early results are positive.

But you know that, being a biotech expert, so why are you constantly trying to deceive others?

"Recruitment is expected to be complete by the end of 2023 with data available in H1 2024"

Is this what you're referring to? From 19 Sept. 2023.

I'm sure this was guidance from the trial at the time it was made.

So we have slipped 6 months - this is a cutting edge trial in a cutting edge biotech, and it is not just LD that determines the timelines - there are multiple stakeholders involved as you well know. To suggest she lied is probably libellous, so I would consider very carefully what you are writing.

A 6 month slippage would be a big deal if Scancell were building plastic toys for cereal packets, but they are not.

Violin, Scancell have been offered plenty of deals (my opinion, plus I think it has been mentioned in interviews?), but they are not good enough!

I doubt very much if the release of results is geared towards a particular event, as Scancell have limited control over when the results are available. It depends on the NHS / oncologists / trial organiser

Q4 was the estimate and this was reinforced in recent results release - this indicates earlier rather than later Q4 to me. So could be literally any day.

A 10 trade at full ask?

That's urban myth for 'I need shares'

It's just your subconscious getting the better of you, violin!

"If you keep seeing the number 72 repeatedly, it may be a sign or message from the universe or your subconscious. Some people believe in the concept of angel numbers, which are sequences of numbers that hold spiritual or mystical significance. In this context, 72 may represent balance, harmony, and spiritual growth"

Not actually down Matt, appears down due to the high closing price of the UT trade near close yesterday.

Or if you really want to claim it's down, then it's down the same amount as it was up yesterday.

Truth is, nobody knows. It is up to the trial regulators, not Scancell.

I don't see how the timing of the AGM is a factor. As previously stated, could be any day.

Oh dear, "significant wait", c'mon you can do better than that.

Results could be literally any day, it is now Q4 when scib1 results are due.

Anything over 14p is a buy today - I know, have topped up at 14.045.

Can sell on auto up to 70000 at 13.8

"very little to say" - wow.

This has probably been the most news intensive year of Scancell to date (and overwhelmingly positive). There is almost too much to say.

Ruck, you don't RNS on every meeting, discussion etc...

News will come when it's definitely news.

Don't see any rational justification for the sp from you though? Just a template negative comment with no analysis.

Maybe you are an English student practicing irony.. or is it hypocrisy?

Lots of rational justification here for a much higher sp.